Notice2024-16054
National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 22, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 140 (Monday, July 22, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 140 (Monday, July 22, 2024)]
[Notices]
[Page 59124]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-16054]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Amended Notice of
Meeting
Notice is hereby given of a change in the meeting of the National
Heart, Lung, and Blood Institute Special Emphasis Panel, Catalyze
Product Definition, August 15, 2024, 10:00 a.m. to 2:00 p.m., National
Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD
20892 which was published in the Federal Register on July 16, 2024, 89
FR 57916.
This meeting is being amended due to a change the meeting date. The
meeting will be held on September 13, 2024, from 10:00 a.m. to 2:00
p.m. The meeting is closed to the public.
Dated: July 17, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-16054 Filed 7-19-24; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on July 22, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.